Vincenzo Di Pilato
Overview
Explore the profile of Vincenzo Di Pilato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boncompagni S, Riccobono E, Cusi M, Di Pilato V, Rossolini G
Antimicrob Agents Chemother
. 2025 Jan;
69(2):e0155424.
PMID: 39817763
A strain positive for the metallo-beta-lactamase gene and resistant to trimethoprim-sulfamethoxazole was unexpectedly isolated from a surveillance rectal swab. The characterization of the strain revealed carriage of a 91 kb...
2.
Vena A, Tiseo G, Falcone M, Bartalucci C, Marelli C, Cesaretti M, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39810592
Background: This study assesses the impact of fluconazole resistance on 30-day all-cause mortality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI). Methods: A multicenter retrospective study was...
3.
Magri C, De Carolis E, Ivagnes V, Di Pilato V, Spruijtenburg B, Marchese A, et al.
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597542
In 2019, became the first fungal pathogen included in the list of the urgent antimicrobial threats by the Centers for Disease Control (CDC). Short tandem repeat (STR) analysis and whole-genome...
4.
Integral genomic description of bla-harbouring plasmids recovered from Enterobacterales in Argentina
Gonzalez-Espinosa F, Di Pilato V, Calabrese L, Costa E, Costa A, Gutkind G, et al.
J Glob Antimicrob Resist
. 2024 Oct;
39:224-226.
PMID: 39477069
Objective: To characterise four bla-harbouring plasmids recovered in Enterobacterales isolated in Argentina. Methods: DNA was sequenced by Illumina and Oxford Nanopore Technologies, assembled using Unicycler, analysed using PlasmidFinder, MOB-Typer, IslandViewer4,...
5.
Traini C, Bulli I, Sarti G, Morecchiato F, Coppi M, Rossolini G, et al.
Nutrients
. 2024 Aug;
16(15).
PMID: 39125262
Alzheimer's disease (AD) is a neurodegenerative process responsible for almost 70% of all cases of dementia. The clinical signs consist in progressive and irreversible loss of memory, cognitive, and behavioral...
6.
Giacobbe D, Di Pilato V, Vena A, Marchese A, Bassetti M
Expert Rev Mol Diagn
. 2024 Jul;
24(7):583-590.
PMID: 39054637
Introduction: Carbapenem-resistant Enterobacterales (CRE) causing severe infections in humans have represented an important challenge for clinicians worldwide during the past two decades. Areas Covered: Novel β-lactams and β-lactam/β-lactamase inhibitor combinations...
7.
Giacobbe D, Labate L, Russo Artimagnella C, Marelli C, Signori A, Di Pilato V, et al.
Infect Dis Ther
. 2024 Jul;
13(9):1929-1948.
PMID: 38995601
Introduction: Cefiderocol is a siderophore cephalosporin showing activity against various carbapenem-resistant Gram-negative bacteria (CR-GNB). No data currently exist about real-world use of cefiderocol in terms of types of therapy (e.g.,...
8.
Nannini G, Di Gloria L, Russo E, Sterrantino G, Kiros S, Coppi M, et al.
Microbes Infect
. 2024 Apr;
26(5-6):105339.
PMID: 38636822
Purpose: Few reports focused on the role of oral microbiome diversity in HIV infection. We characterized the microbiota-immunity axis in a cohort of treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy (ART)...
9.
Gonzalez-Espinosa F, Di Pilato V, Magarinos F, Di Conza J, Rossolini G, Gutkind G, et al.
J Glob Antimicrob Resist
. 2024 Apr;
37:176-178.
PMID: 38583573
Objectives: To describe at genomic level nine carbapenemase-producing Klebsiella pneumoniae ST307 (Kp-ST307) clinical isolates recovered in Buenos Aires during 2017 to 2021, investigating their resistome, virulome, and phylogeny. Methods: Antimicrobial...
10.
Mikulska M, Ullah N, Magnasco L, Codda G, Bartalucci C, Miletich F, et al.
Clin Microbiol Infect
. 2024 Mar;
30(6):822-827.
PMID: 38431255
Objectives: The serum (1,3)-beta-d-glucan (BDG) assay gives quicker results and has higher sensitivity than blood cultures, therefore it is advised for early diagnosis of invasive candidemia and/or discontinuation of empirical...